Total Payments
$1.8M
2024 Payments
$327,765
Companies
21
Transactions
324
Medicare Patients
280
Medicare Billing
$34,941
Payment Breakdown by Category
Consulting$1.3M (70.8%)
Other$444,369 (25.0%)
Travel$61,543 (3.5%)
Research$7,131 (0.4%)
Food & Beverage$6,809 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.3M | 111 | 70.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $397,859 | 5 | 22.4% |
| Travel and Lodging | $61,543 | 109 | 3.5% |
| Honoraria | $46,510 | 5 | 2.6% |
| Unspecified | $7,131 | 2 | 0.4% |
| Food and Beverage | $6,809 | 92 | 0.4% |
Payments by Type
General
$1.8M
322 transactions
Research
$7,131
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $920,760 | 69 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $571,945 | 104 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $63,344 | 15 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $54,427 | 32 | $0 (2024) |
| AstraZeneca AB | $50,800 | 5 | $0 (2020) |
| Amgen Inc. | $33,359 | 27 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $23,248 | 19 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $16,808 | 21 | $0 (2022) |
| DiaSorin Inc. | $14,250 | 3 | $0 (2019) |
| Ultragenyx Pharmaceutical Inc. | $9,287 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $327,765 | 65 | AKEBIA THERAPEUTICS INC ($157,102) |
| 2023 | $353,065 | 65 | Pharmacosmos Therapeutics Inc. ($186,196) |
| 2022 | $211,252 | 51 | Pharmacosmos Therapeutics Inc. ($131,961) |
| 2021 | $238,602 | 35 | AKEBIA THERAPEUTICS INC ($148,196) |
| 2020 | $498,369 | 20 | AKEBIA THERAPEUTICS INC ($394,319) |
| 2019 | $22,679 | 16 | Ultragenyx Pharmaceutical Inc. ($9,287) |
| 2018 | $57,256 | 11 | AMAG Pharmaceuticals, Inc. ($51,435) |
| 2017 | $70,645 | 61 | SANOFI-AVENTIS U.S. LLC ($23,248) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AKEBIA THERAPEUTICS INC | — | Consulting Fee | Cash or cash equivalent | $16,250.00 | General |
| 11/25/2024 | WHITEHALL INTERNATIONAL INC | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 10/25/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $62.82 | General |
| 10/23/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $697.54 | General |
| 10/23/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $426.20 | General |
| 10/23/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $76.92 | General |
| 10/23/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $21.47 | General |
| 10/23/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $15.60 | General |
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Honoraria | In-kind items and services | $21,903.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Honoraria | In-kind items and services | $11,000.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Honoraria | In-kind items and services | $5,607.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Travel and Lodging | In-kind items and services | $297.58 | General |
| Category: HEMATOLOGY | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Consulting Fee | In-kind items and services | $96.08 | General |
| Category: HEMATOLOGY | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: HEMATOLOGY | ||||||
| 10/04/2024 | AKEBIA THERAPEUTICS INC | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 10/01/2024 | AKEBIA THERAPEUTICS INC | — | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| 07/16/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Consulting Fee | In-kind items and services | $35,926.75 | General |
| Category: HEMATOLOGY | ||||||
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $589.24 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $451.95 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $64.00 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $32.45 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $23.44 | General |
| 07/09/2024 | AKEBIA THERAPEUTICS INC | — | Travel and Lodging | In-kind items and services | $18.00 | General |
| 06/24/2024 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $21,105.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Ph3 KAI 4169 Secondary HPT 2 | Amgen Inc. | $6,242 | 1 |
| Ph3 Head to Head: Comparison of Cinacalcet vs. AMG 416 in Cinacalcet Naive Subjects | Amgen Inc. | $888.89 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 22 | $3,828 | $1,118 |
| 2022 | 1 | 17 | 25 | $4,350 | $1,320 |
| 2021 | 6 | 189 | 366 | $100,204 | $24,803 |
| 2020 | 4 | 61 | 131 | $31,527 | $7,699 |
Total Patients
280
Total Services
544
Medicare Billing
$34,941
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 22 | $3,828 | $1,118 | 29.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 25 | $4,350 | $1,320 | 30.4% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 30 | 106 | $38,478 | $7,039 | 18.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 81 | $20,250 | $6,575 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 104 | $18,096 | $5,774 | 31.9% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 32 | 40 | $13,600 | $2,227 | 16.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,920 | $1,664 | 33.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 20 | 20 | $4,860 | $1,524 | 31.4% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2020 | 16 | 47 | $17,061 | $3,105 | 18.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 43 | $7,482 | $2,421 | 32.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 18 | $4,500 | $1,472 | 32.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 23 | $2,484 | $700.90 | 28.2% |
About Dr. Myles Wolf, MD
Dr. Myles Wolf, MD is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629069927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Myles Wolf, MD has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $327,765 received in 2024. These payments were reported across 324 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($1.3M).
As a Medicare-enrolled provider, Wolf has provided services to 280 Medicare beneficiaries, totaling 544 services with total Medicare billing of $34,941. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Chicago, IL
- Active Since 11/04/2005
- Last Updated 12/12/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629069927
Products in Payments
- MONOFERRIC (Drug) $454,173
- Monoferric (Drug) $117,773
- FERAHEME (Drug) $63,344
- Auryxia (Drug) $58,918
- Parsabiv (Biological) $17,603
- Kerendia (Drug) $15,308
- NO PRODUCT DISCUSSED (Drug) $14,455
- Sensipar (Drug) $12,522
- ULTOMIRIS (Biological) $10,022
- CRYSVITA (Drug) $9,287
- RENVELA (Drug) $8,794
- INJECTAFER (Drug) $8,151
- AURYXIA (Drug) $5,250
- HEMANGEOL (Drug) $4,750
- Non-Covered $1,500
- Rayaldee (Drug) $69.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chicago
Dr. Merle Diamond, Md, MD
Internal Medicine — Payments: $1.4M
Internal Medicine $1.4M
Dr. Elizabeth Kiracofe, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Robert Kushner, Md, MD
Internal Medicine — Payments: $549,886
Internal Medicine $549,886
Dr. Adam Stein, M.d, M.D
Internal Medicine — Payments: $503,325
Internal Medicine $503,325
Devalingam Mahalingam, M.d, M.D
Internal Medicine — Payments: $501,247
Internal Medicine $501,247
Dr. Romeo Ursua, M.d, M.D
Internal Medicine — Payments: $410,468
Internal Medicine $410,468